• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Theragnostic Target, Prostate-Specific Membrane Antigen-Also Specific for Nonprostatic Malignancies.

作者信息

Ramirez-Fort Marigdalia K, Mahase Sean S, Osborne Joseph R, Lange Christopher S

机构信息

Department of Radiation Oncology, Medical University of South Carolina, Charleston, South Carolina; Department of Urology, Weill Cornell Medicine, New York, New York.

Department of Radiation Oncology, Weill Cornell Medicine, New York, New York.

出版信息

Int J Radiat Oncol Biol Phys. 2018 Jul 1;101(3):646-649. doi: 10.1016/j.ijrobp.2018.03.061. Epub 2018 Apr 5.

DOI:10.1016/j.ijrobp.2018.03.061
PMID:29893276
Abstract
摘要

相似文献

1
Theragnostic Target, Prostate-Specific Membrane Antigen-Also Specific for Nonprostatic Malignancies.治疗诊断靶点，前列腺特异性膜抗原——也对非前列腺恶性肿瘤具有特异性。
Int J Radiat Oncol Biol Phys. 2018 Jul 1;101(3):646-649. doi: 10.1016/j.ijrobp.2018.03.061. Epub 2018 Apr 5.
2
The Ga/Lu theragnostic concept in PSMA targeting of castration-resistant prostate cancer: correlation of SUV values and absorbed dose estimates.镓/镥治疗诊断一体化概念在去势抵抗性前列腺癌的前列腺特异性膜抗原靶向治疗中的应用：标准化摄取值与吸收剂量估计值的相关性
Eur J Nucl Med Mol Imaging. 2017 May;44(5):788-800. doi: 10.1007/s00259-016-3609-9. Epub 2017 Jan 12.
3
Schmorl's Node: Confusion Still Persists in 68Ga-Prostate-Specific Membrane Antigen Ligand PET/CT.Schmorl 结节：68Ga-前列腺特异性膜抗原配体 PET/CT 仍存在困惑。
Clin Nucl Med. 2018 Sep;43(9):679-681. doi: 10.1097/RLU.0000000000002196.
4
Molecular imaging of glutamate-carboxypeptidase II (prostate-specific membrane antigen) in malignant epithelioid hemangioendothelioma.恶性上皮样血管内皮瘤中谷氨酸羧肽酶II（前列腺特异性膜抗原）的分子成像
Eur J Nucl Med Mol Imaging. 2015 Nov;42(12):1943-4. doi: 10.1007/s00259-015-3161-z. Epub 2015 Aug 12.
5
Current Status of Prostate-Specific Membrane Antigen Targeting in Nuclear Medicine: Clinical Translation of Chelator Containing Prostate-Specific Membrane Antigen Ligands Into Diagnostics and Therapy for Prostate Cancer.核医学中前列腺特异性膜抗原靶向的现状：含前列腺特异性膜抗原配体的螯合剂在前列腺癌诊断与治疗中的临床转化
Semin Nucl Med. 2016 Sep;46(5):405-18. doi: 10.1053/j.semnuclmed.2016.04.004.
6
Prostate-Specific Membrane Antigen Ligands for Imaging and Therapy.用于成像和治疗的前列腺特异性膜抗原配体
J Nucl Med. 2017 Sep;58(Suppl 2):67S-76S. doi: 10.2967/jnumed.116.186767.
7
Why Targeting of PSMA Is a Valuable Addition to the Management of Castration-Resistant Prostate Cancer: The Urologist's Point of View.为何靶向前列腺特异性膜抗原（PSMA）是去势抵抗性前列腺癌治疗的重要补充：泌尿外科医生的观点
J Nucl Med. 2017 Aug;58(8):1207-1209. doi: 10.2967/jnumed.117.194753. Epub 2017 May 18.
8
New Strategies in Prostate Cancer: Prostate-Specific Membrane Antigen (PSMA) Ligands for Diagnosis and Therapy.前列腺癌的新策略：用于诊断和治疗的前列腺特异性膜抗原（PSMA）配体。
Clin Cancer Res. 2016 Jan 1;22(1):9-15. doi: 10.1158/1078-0432.CCR-15-0820.
9
Radiolabeled enzyme inhibitors and binding agents targeting PSMA: Effective theranostic tools for imaging and therapy of prostate cancer.靶向前列腺特异性膜抗原（PSMA）的放射性标记酶抑制剂和结合剂：用于前列腺癌成像和治疗的有效诊疗工具。
Nucl Med Biol. 2016 Nov;43(11):692-720. doi: 10.1016/j.nucmedbio.2016.08.006. Epub 2016 Aug 11.
10
Prostate-specific membrane antigen radioligand therapy of prostate cancer.前列腺癌的前列腺特异性膜抗原放射性配体疗法
Q J Nucl Med Mol Imaging. 2019 Mar;63(1):29-36. doi: 10.23736/S1824-4785.19.03155-8. Epub 2019 Jan 15.

引用本文的文献

1
Gender and disease-inclusive nomenclature consolidation of theragnostic target, prostate-specific membrane antigen (PSMA) to folate hydrolase-1 (FOLH1).治疗诊断靶点前列腺特异性膜抗原（PSMA）至叶酸水解酶-1（FOLH1）的性别及疾病包容性命名法整合
Front Med (Lausanne). 2024 Feb 9;10:1304718. doi: 10.3389/fmed.2023.1304718. eCollection 2023.
2
Novel Biological and Molecular Characterization in Radiopharmaceutical Preclinical Design.放射性药物临床前设计中的新型生物学和分子特征
J Clin Med. 2021 Oct 21;10(21):4850. doi: 10.3390/jcm10214850.
3
Folate hydrolase-1 (FOLH1) is a novel target for antibody-based brachytherapy in Merkel cell carcinoma.
叶酸水解酶-1（FOLH1）是默克尔细胞癌中基于抗体的近距离放射治疗的新靶点。
Skin Health Dis. 2021 Mar;1(1). doi: 10.1002/ski2.9. Epub 2020 Nov 28.
4
Prostatic irradiation-induced sexual dysfunction: A review and multidisciplinary guide to management in the radical radiotherapy era (Part II on Urological Management).前列腺放疗引起的性功能障碍：根治性放疗时代的综述及多学科管理指南（第二部分：泌尿外科管理）
Rep Pract Oncol Radiother. 2020 Jul-Aug;25(4):619-624. doi: 10.1016/j.rpor.2020.03.011. Epub 2020 May 6.
5
F-FDG PET/CT and Urothelial Carcinoma: Impact on Management and Prognosis-A Multicenter Retrospective Study.F-FDG PET/CT与尿路上皮癌：对治疗及预后的影响——一项多中心回顾性研究
Cancers (Basel). 2019 May 20;11(5):700. doi: 10.3390/cancers11050700.